Healthcare fundraising continues surge
After a record year in 2021, venture fundraising continued to surge, reaching $15.8 billion halfway through 2022 despite poor IPO performance and fear of valuation inflation.
Strong early-stage investment braces for slowdown
Early-stage investment in all four sectors is on track to rival 2021. However, the decline of investment in both early and later stage in Q2 may indicate a slowdown for H2 2022 as many companies look for additional funding to make cash last through 2023.
IPOs and M&As stall
After record venture-backed healthcare exits in 2021, IPOs and M&A were down across all sectors in H1 2022 due to public market volatility.